$ZD
ZIFF DAVIS, INC.

2024 Q2 Form 10-Q Financial Statement

#000108404824000047 Filed on May 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $320.8M $314.5M $389.9M
YoY Change -1.6% 2.39% -1.72%
Cost Of Revenue $52.59M $47.07M $48.62M
YoY Change 10.9% 2.92% -4.39%
Gross Profit $268.2M $267.4M $341.3M
YoY Change -3.73% 2.3% -1.33%
Gross Profit Margin 83.61% 85.03% 87.53%
Selling, General & Admin $222.8M $213.8M $245.0M
YoY Change 0.43% -1.57% 24.51%
% of Gross Profit 83.09% 79.94% 71.8%
Research & Development $16.80M $17.77M $15.53M
YoY Change -5.74% -0.78% -14.71%
% of Gross Profit 6.26% 6.65% 4.55%
Depreciation & Amortization $52.14M $48.45M $69.63M
YoY Change -8.29% -11.3% 18.99%
% of Gross Profit 19.44% 18.12% 20.4%
Operating Expenses $239.6M $231.6M $260.6M
YoY Change -0.02% -17.54% 3.23%
Operating Profit $28.57M $35.86M $80.72M
YoY Change -26.55% 36.28% -13.63%
Interest Expense -$1.804M -$12.47M -$1.186M
YoY Change -86.81% -49.02% -145.16%
% of Operating Profit -6.31% -34.78% -1.47%
Other Income/Expense, Net $5.267M -$104.0K -$3.486M
YoY Change -450.43% -88.55% -22.96%
Pretax Income $35.08M $19.50M $76.05M
YoY Change 47.95% 1977.0% -16.94%
Income Tax $6.990M $8.231M $12.96M
% Of Pretax Income 19.92% 42.2% 17.04%
Net Earnings $36.91M $10.63M $63.42M
YoY Change 121.3% -239.33% -5.97%
Net Earnings / Revenue 11.51% 3.38% 16.27%
Basic Earnings Per Share $0.81 $0.23
Diluted Earnings Per Share $0.77 $0.23 $1.24
COMMON SHARES
Basic Shares Outstanding 46.13M shares 46.07M shares 45.98M shares
Diluted Shares Outstanding 50.67M shares 45.96M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $687.2M $751.2M $764.7M
YoY Change -3.87% -1.23% 7.52%
Cash & Equivalents $687.2M $734.8M $737.6M
Short-Term Investments $0.00 $16.40M $27.11M
Other Short-Term Assets $93.53M $95.04M $88.57M
YoY Change 26.31% 39.13% 29.64%
Inventory
Prepaid Expenses
Receivables $450.4M $446.9M $337.7M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.231B $1.293B $1.191B
YoY Change 14.54% 16.86% 9.84%
LONG-TERM ASSETS
Property, Plant & Equipment $192.3M $190.9M $188.2M
YoY Change -0.05% 2.07% 5.6%
Goodwill $1.626B $1.625B $1.546B
YoY Change 1.65% 1.69% -2.85%
Intangibles $385.8M $400.6M $325.4M
YoY Change -3.94% -7.56% -29.69%
Long-Term Investments $111.0M $99.00M $99.90M
YoY Change 11.78% -1.0% -11.03%
Other Assets $67.13M $69.15M $70.75M
YoY Change -13.5% -11.29% -11.71%
Total Long-Term Assets $2.433B $2.434B $2.280B
YoY Change 1.6% 0.56% -6.9%
TOTAL ASSETS
Total Short-Term Assets $1.231B $1.293B $1.191B
Total Long-Term Assets $2.433B $2.434B $2.280B
Total Assets $3.664B $3.727B $3.471B
YoY Change 5.61% 5.67% -1.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $367.9M $360.2M $123.3M
YoY Change 189.35% 150.17% 2.01%
Accrued Expenses $58.42M $70.27M $93.68M
YoY Change -32.35% -27.01% 322.88%
Deferred Revenue $198.4M $199.9M $184.5M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $643.8M $663.3M $431.8M
YoY Change 47.65% 50.35% -0.14%
LONG-TERM LIABILITIES
Long-Term Debt $1.002B $1.002B $1.001B
YoY Change 0.23% 0.23% 0.23%
Other Long-Term Liabilities $74.50M $78.88M $46.67M
YoY Change -21.91% -31.2% -32.36%
Total Long-Term Liabilities $1.077B $1.081B $1.048B
YoY Change -1.7% -3.01% -1.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $643.8M $663.3M $431.8M
Total Long-Term Liabilities $1.077B $1.081B $1.048B
Total Liabilities $1.794B $1.825B $1.578B
YoY Change 11.66% 11.8% -3.82%
SHAREHOLDERS EQUITY
Retained Earnings $1.472B $1.504B $1.492B
YoY Change -1.43% -1.75% -2.98%
Common Stock $447.0K $461.0K $461.0K
YoY Change -3.66% -2.54% -2.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.870B $1.902B $1.893B
YoY Change
Total Liabilities & Shareholders Equity $3.664B $3.727B $3.471B
YoY Change 5.61% 5.67% -1.76%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $36.91M $10.63M $63.42M
YoY Change 121.3% -239.33% -5.97%
Depreciation, Depletion And Amortization $52.14M $48.45M $69.63M
YoY Change -8.29% -11.3% 18.99%
Cash From Operating Activities $50.56M $75.56M $92.12M
YoY Change 27.28% -34.47% 113.12%
INVESTING ACTIVITIES
Capital Expenditures $25.50M $28.13M $26.25M
YoY Change 1.07% -6.29% 3.21%
Acquisitions $44.52M
YoY Change 456.48%
Other Investing Activities $13.84M $66.00K $3.583M
YoY Change -1167.46% -98.33% -20.85%
Cash From Investing Activities -$11.66M -$71.48M -$22.67M
YoY Change -56.05% 84.27% 8.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -85.45M -$6.311M 2.019M
YoY Change 55.0% -33.45% 102.51%
NET CHANGE
Cash From Operating Activities 50.56M $75.56M 92.12M
Cash From Investing Activities -11.66M -$71.48M -22.67M
Cash From Financing Activities -85.45M -$6.311M 2.019M
Net Change In Cash -46.54M -$2.833M 71.47M
YoY Change 11.0% -104.12% 206.57%
FREE CASH FLOW
Cash From Operating Activities $50.56M $75.56M $92.12M
Capital Expenditures $25.50M $28.13M $26.25M
Free Cash Flow $25.06M $47.43M $65.87M
YoY Change 72.89% -44.39% 270.28%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46134708 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
46134708 shares
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P9M
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
47067000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
45730000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
117000000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
115920000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17774000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17914000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
96783000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
101263000 usd
CY2024Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
278624000 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
280827000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
35861000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
26315000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1769000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-4480000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-3780000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-10705000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-20345000 usd
CY2024Q1 zd Available For Sale Debt Securities And Equity Securities Without Readily Determinable Fair Value Gain Loss
AvailableForSaleDebtSecuritiesAndEquitySecuritiesWithoutReadilyDeterminableFairValueGainLoss
0 usd
CY2023Q1 zd Available For Sale Debt Securities And Equity Securities Without Readily Determinable Fair Value Gain Loss
AvailableForSaleDebtSecuritiesAndEquitySecuritiesWithoutReadilyDeterminableFairValueGainLoss
357000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-104000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-908000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
19503000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
939000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8231000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-616000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-645000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-9182000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
10627000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-7627000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45860033 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46987249 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45955365 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46987249 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
10627000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-7627000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6530000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3713000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-19000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
109000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-63000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
324000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6593000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4037000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4034000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3590000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
10627000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-7627000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48453000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
54623000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2770000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2933000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
8872000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
8402000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
50000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
441000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2709000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-7442000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-3780000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
CY2024Q1 zd Gain Loss On Investments Noncash
GainLossOnInvestmentsNoncash
-645000 usd
CY2023Q1 zd Gain Loss On Investments Noncash
GainLossOnInvestmentsNoncash
-9182000 usd
CY2024Q1 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
-10705000 usd
CY2023Q1 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
-20345000 usd
CY2024Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
357000 usd
CY2024Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1278000 usd
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
2776000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-55365000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-27626000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9423000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7658000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2078000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2048000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-62270000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6922000 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
15169000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
12085000 usd
CY2024Q1 zd Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-5676000 usd
CY2023Q1 zd Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-4896000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
75558000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
115307000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28129000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30017000 usd
CY2024Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
44524000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
8001000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
0 usd
CY2023Q1 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
3174000 usd
CY2024Q1 us-gaap Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
1238000 usd
CY2023Q1 us-gaap Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
0 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
66000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
3947000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-71481000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-38791000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3923000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2875000 usd
CY2024Q1 zd Payments Of Deferred Consideration Related To Acquisition
PaymentsOfDeferredConsiderationRelatedToAcquisition
2418000 usd
CY2023Q1 zd Payments Of Deferred Consideration Related To Acquisition
PaymentsOfDeferredConsiderationRelatedToAcquisition
6679000 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
30000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
71000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6311000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9483000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-599000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1676000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2833000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
68709000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
737612000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
652793000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
734779000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
721502000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1892998000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
10627000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-19000 usd
CY2024Q1 zd Other Comprehensive Income Loss Net Of Tax Excluding Separation Adjustments
OtherComprehensiveIncomeLossNetOfTaxExcludingSeparationAdjustments
-6593000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-3923000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8872000 usd
CY2024Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
-31000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1902012000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1892611000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-7627000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
109000 usd
CY2023Q1 zd Other Comprehensive Income Loss Net Of Tax Excluding Separation Adjustments
OtherComprehensiveIncomeLossNetOfTaxExcludingSeparationAdjustments
4037000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-2875000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8402000 usd
CY2023Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
-67000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1894615000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
314485000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
307142000 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
74100000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
65100000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
44100000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.61
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.30
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.09
CY2024Q1 us-gaap Business Combination Pro Forma Information Revenue Of Acquiree Since Acquisition Date Actual
BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
7500000 usd
CY2023Q4 zd Equity Securities Shares Owned
EquitySecuritiesSharesOwned
1000000 shares
CY2024Q1 zd Equity Securities Shares Owned
EquitySecuritiesSharesOwned
1000000 shares
CY2024Q1 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
16400000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
27100000 usd
CY2024Q1 zd Sale Of Stock Number Of Shares Sold In Transaction
SaleOfStockNumberOfSharesSoldInTransaction
0 shares
CY2023Q1 zd Sale Of Stock Number Of Shares Sold In Transaction
SaleOfStockNumberOfSharesSoldInTransaction
52393 shares
CY2024Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-10705000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-19988000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
357000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-10705000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-20345000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
600000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
700000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
0 investment
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
0 investment
CY2024Q1 zd Debt Securities Available For Sale Impairment Losses
DebtSecuritiesAvailableForSaleImpairmentLosses
0 usd
CY2023Q1 zd Debt Securities Available For Sale Impairment Losses
DebtSecuritiesAvailableForSaleImpairmentLosses
0 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-600000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-9200000 usd
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
99000000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
99900000 usd
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
16400000 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
27100000 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-10700000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-20300000 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
5768000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
1546065000 usd
CY2024Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
85900000 usd
CY2024Q1 us-gaap Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
3983000 usd
CY2024Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-3354000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
1624628000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1520606000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1120044000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
400562000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1420232000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1094826000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
325406000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
26300000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
33300000 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
2386000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
2463000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6263000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1001884000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1001312000 usd
CY2024Q1 zd Long Term Debt Maturity Principal Year Four
LongTermDebtMaturityPrincipalYearFour
550000000 usd
CY2024Q1 zd Long Term Debt Maturity Principal After Year Five
LongTermDebtMaturityPrincipalAfterYearFive
460000000 usd
CY2024Q1 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
28100000 usd
CY2023Q4 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
28100000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.422
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.656
CY2024Q1 zd Discrete Income Tax Expense Benefit From Valutation Allowance Recognition Against U.S.Capital Loss Carryforwards
DiscreteIncomeTaxExpenseBenefitFromValutationAllowanceRecognitionAgainstU.S.CapitalLossCarryforwards
3200000 usd
CY2023Q1 zd Discrete Income Tax Expense Benefit From Gain On Investments
DiscreteIncomeTaxExpenseBenefitFromGainOnInvestments
-5000000.0 usd
CY2023Q1 zd Discrete Income Tax Expense Benefit From Release Of Reserves For Uncertain Tax Positions
DiscreteIncomeTaxExpenseBenefitFromReleaseOfReservesForUncertainTaxPositions
-1000000.0 usd
CY2024Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
36600000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
36100000 usd
CY2024Q1 us-gaap Prepaid Taxes
PrepaidTaxes
3400000 usd
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
4700000 usd
CY2024Q1 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
4741308 shares
CY2024Q1 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
58237 shares
CY2023Q1 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
36652 shares
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3900000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2900000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
435135 shares
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8872000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8402000 usd
CY2024Q1 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Diluted
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
10627000 usd
CY2024Q1 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
10627000 usd
CY2023Q1 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Diluted
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
-7627000 usd
CY2023Q1 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-7627000 usd
CY2024Q1 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0 usd
CY2023Q1 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10627000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
10627000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-7627000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7627000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45860033 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46987249 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
95332 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45955365 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46987249 shares
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.23
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.16
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.23
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.16
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
314485000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
307142000 usd
CY2024Q1 zd Direct Costs By Segment
DirectCostsBySegment
278624000 usd
CY2023Q1 zd Direct Costs By Segment
DirectCostsBySegment
280827000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
35861000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
26315000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6511000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5329000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 usd
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001084048-24-000047-index-headers.html Edgar Link pending
0001084048-24-000047-index.html Edgar Link pending
0001084048-24-000047.txt Edgar Link pending
0001084048-24-000047-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zd-20240331.htm Edgar Link pending
zd-20240331.xsd Edgar Link pending
zd-20240331_g1.jpg Edgar Link pending
zd20240331ex-101.htm Edgar Link pending
zd20240331ex-102.htm Edgar Link pending
zd20240331ex-103.htm Edgar Link pending
zd20240331ex-311.htm Edgar Link pending
zd20240331ex-312.htm Edgar Link pending
zd20240331ex-321.htm Edgar Link pending
zd20240331ex-322.htm Edgar Link pending
zd-20240331_cal.xml Edgar Link unprocessable
zd-20240331_def.xml Edgar Link unprocessable
zd-20240331_lab.xml Edgar Link unprocessable
zd-20240331_pre.xml Edgar Link unprocessable
zd-20240331_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable